HIV-1 enhancing effect of prostatic acid phosphatase peptides is reduced in human seminal plasma

Julie A Martellini1, Amy L Cole, Pavel Svoboda

  • 1Department of Molecular Biology & Microbiology, Biomolecular Science Center, Burnett School of Biomedical Sciences at the University of Central Florida College of Medicine, Orlando, Florida, United States of America.

Plos One
|February 2, 2011
PubMed

Insights

Human seminal plasma (SP) contains factors that inhibit HIV-1. While certain SP peptides (SEVI) can enhance infection, SP

Area of Science:

  • Virology
  • Biochemistry

Background:

  • Human seminal plasma (SP) possesses innate antimicrobial properties.
  • Naturally occurring peptidic fragments from prostatic acid phosphatase (PAP) form amyloid fibrils (SEVI), which can enhance HIV-1 infection in vitro.

Purpose of the Study:

  • To investigate the biological consequence of SEVI's proviral effect in the presence of human SP.
  • To determine if SP can counteract the proviral activity of PAP-derived peptides and SEVI.

Main Methods:

  • PAP-derived peptides were agitated to form SEVI and incubated with or without human SP.
  • Anti-HIV-1 assays were performed to assess proviral activity.
  • SP's concentration-dependent activity and proteolytic degradation of SEVI were analyzed.
  • The role of specific SP proteases (PSA, matriptase) in degrading PAP peptides and SEVI was examined.

Main Results:

  • Human SP (1% concentration) significantly inhibited the proviral activity of PAP peptides and SEVI in anti-HIV-1 assays.
  • SP's anti-HIV-1 activity was concentration-dependent and reduced by filtration.
  • SP demonstrated proteolytic activity, degrading PAP peptides and SEVI within hours, even at high dilutions (1:200).
  • Prostate-specific antigen (PSA) and matriptase in SP could degrade both PAP peptides and SEVI.

Conclusions:

  • Human seminal plasma contains both antiviral and proviral factors regarding HIV-1.
  • Proteolytic components within human SP, including PSA and matriptase, can degrade PAP peptides and SEVI.
  • These naturally occurring proteases may reduce the proviral activity of SEVI in vivo.